Skip to main content
OpenTrials
Completed

NCT Number: NCT00399191

A Test of Iron Malabsorption in Patients With Iron Deficiency Anemia

The objective of the study is to develop a simple, noninvasive test for evaluation of iron absorption as a tool to determine the cause of iron deficiency anemia. Healthy, premenopausal women with iron deficiency with or without anemia will be recruited for the study. Participants will, over the course of two months, ingest an iron solution three times; after each iron ingestion, participants will collect their stool and bring it to the study investigators for assessment of iron content.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 1

Primary location

UT Southwestern

Dallas, Texas, 75390, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ferritin <40

Exclusion criteria

  • pregnant,
  • post-partum,
  • s/p GIT surgery,
  • known malabsorption,
  • coeliac disease,
  • Helicobacter pylori

Treatment and study plan

stable isotope of iron, dysprosium

Drug

Primary outcomes

  1. initial mucosal uptake of iron

  2. intra- and inter-individual variability

  3. red cell incorporation of iron

Sponsors and collaborators

Lead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Nih

Registry information

Important dates

Study start
2006
First posted
Nov 14, 2006
Registry last updated
Mar 18, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.